Attached files
| file | filename |
|---|---|
| 10-K/A - ENZON PHARMACEUTICALS, INC. | c62001_10ka.htm |
| EX-23 - ENZON PHARMACEUTICALS, INC. | c62001_ex23.htm |
| EX-31.1 - ENZON PHARMACEUTICALS, INC. | c62001_ex31-1.htm |
EXHIBIT 31.2
CERTIFICATION PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Craig A. Tooman, certify that:
|
|
|
|
|
|
1. |
I have reviewed this Amendment No. 2 to the annual report on Form 10-K of Enzon Pharmaceuticals, Inc.; and |
|
|
|
|
|
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
|
|
|
|
|
Date: June 30, 2010 |
By: |
/s/ Craig A. Tooman |
|
|
|
|
|
|
|
Craig A. Tooman |
|
|
|
Executive Vice President, Finance and |
|
|
|
Chief Financial Officer |
|
|
|
(Principal Financial Officer and |
|
|
|
Principal Accounting Officer) |